Application of metagenomic next-generation sequencing in patients with infective endocarditis
- PMID: 36816587
- PMCID: PMC9936084
- DOI: 10.3389/fcimb.2023.1107170
Application of metagenomic next-generation sequencing in patients with infective endocarditis
Abstract
Objectives: Metagenomic next-generation sequencing (mNGS) technology is helpful for the early diagnosis of infective endocarditis, especially culture-negative infective endocarditis, which may guide clinical treatment. The purpose of this study was to compare the presence of culture-negative infective endocarditis pathogens versus culture-positive ones, and whether mNGS test results could influence treatment regimens for patients with routine culture-negative infective endocarditis.
Methods: The present study enrolled patients diagnosed with infective endocarditis and tested for mNGS in the First Affiliated Hospital of Zhengzhou University from February 2019 to February 2022 continuously. According to the culture results, patients were divided into culture-negative group (Group CN, n=18) and culture-positive group (Group CP, n=32). The baseline characteristics, clinical data, pathogens, 30 day mortality and treatment regimen of 50 patients with infective endocarditis were recorded and analyzed.
Results: Except for higher levels of PCT in the Group CN [0.33 (0.16-2.74) ng/ml vs. 0.23 (0.12-0.49) ng/ml, P=0.042], there were no significant differences in the basic clinical data and laboratory examinations between the two groups (all P>0.05). The aortic valve and mitral valve were the most involved valves in patients with infective endocarditis (aortic valve involved: Group CN 10, Group CP 16; mitral valve involved: Group CN 8, Group CP 21; P>0.05) while 9 patients had multiple valves involved (Group CN 2, Group CP 7; P>0.05). The detection rate of non-streptococci infections in the Group CN was significantly higher than that in the Group CP (9/18 vs. 3/32, P=0.004). There was no significant difference in patients with heart failure hospitalization and all-cause death at 30 days after discharge (3 in Group CN vs. 4 in Group CP, P>0.05). It is worth noting that 10 patients with culture-negative infective endocarditis had their antibiotic regimen optimized after the blood mNGS.
Conclusions: Culture-negative infective endocarditis should be tested for mNGS for early diagnosis and to guide clinical antibiotic regimen.
Keywords: antibiotic regimen; culture-negative; culture-positive; infective endocarditis; metagenomic next-generation sequencing.
Copyright © 2023 Li, Zhao, Tao, Yue and Zhao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The clinical value of valve metagenomic next-generation sequencing when applied to the etiological diagnosis of infective endocarditis.Ann Transl Med. 2021 Oct;9(19):1490. doi: 10.21037/atm-21-2488. Ann Transl Med. 2021. PMID: 34805352 Free PMC article.
-
Infective endocarditis caused by Streptococcus sinensis diagnosed with next-generation sequencing: a case report and literature review.BMC Infect Dis. 2025 Mar 27;25(1):425. doi: 10.1186/s12879-025-10837-2. BMC Infect Dis. 2025. PMID: 40148753 Free PMC article. Review.
-
Identification of causative agents of infective endocarditis by metagenomic next-generation sequencing of resected valves.Front Cell Infect Microbiol. 2025 Mar 13;15:1532257. doi: 10.3389/fcimb.2025.1532257. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40182766 Free PMC article.
-
Comprehensive analysis of culture-negative periprosthetic joint infection with metagenomic next-generation sequencing.Front Cell Infect Microbiol. 2025 May 9;15:1564488. doi: 10.3389/fcimb.2025.1564488. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40415958 Free PMC article.
-
Unveiling the Future of Infective Endocarditis Diagnosis: The Transformative Role of Metagenomic Next-Generation Sequencing in Culture-Negative Cases.J Epidemiol Glob Health. 2025 Aug 22;15(1):108. doi: 10.1007/s44197-025-00455-1. J Epidemiol Glob Health. 2025. PMID: 40847264 Free PMC article. Review.
Cited by
-
Illuminating the Challenges and Diagnostic Utility of Plasma Microbial Cell-Free DNA Sequencing in Suspected Infective Endocarditis: A Retrospective Observational Cohort Study.Open Forum Infect Dis. 2025 Feb 17;12(3):ofaf099. doi: 10.1093/ofid/ofaf099. eCollection 2025 Mar. Open Forum Infect Dis. 2025. PMID: 40046887 Free PMC article.
-
Metagenomic next-generation sequencing of plasma cell-free DNA improves the early diagnosis of suspected infections.BMC Infect Dis. 2024 Feb 12;24(1):187. doi: 10.1186/s12879-024-09043-3. BMC Infect Dis. 2024. PMID: 38347444 Free PMC article.
-
Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-free DNA Testing in the Management of Patients With Suspected Infectious Diseases.Open Forum Infect Dis. 2023 Jul 24;10(8):ofad385. doi: 10.1093/ofid/ofad385. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37601730 Free PMC article.
-
Blood culture-negative infective endocarditis: are we looking hard enough?Infection. 2023 Dec;51(6):1629-1631. doi: 10.1007/s15010-023-02097-6. Epub 2023 Oct 4. Infection. 2023. PMID: 37792178 Free PMC article. Review.
-
Bacterial Diversity in Native Heart Valves in Infective Endocarditis.Biomedicines. 2025 Jan 20;13(1):245. doi: 10.3390/biomedicines13010245. Biomedicines. 2025. PMID: 39857828 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous